Dianthus Therapeutics's total assets for Q3 2025 were $577.45M, an increase of 77.09% from the previous quarter. DNTH total liabilities were $30.99M for the fiscal quarter, a 34.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.